Home › Interstitial Lung Diseases › Tennessee
Interstitial Lung Diseases clinical trials in Tennessee
6 studies for Interstitial Lung Diseases are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Nov 13, 2026 · NCT07201922Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Vanderbilt University, Nashville
RecruitingObservational study
Ages 21 and older · All sexes · Updated Nov 12, 2026 · NCT01915511Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Tennessee, Knoxville
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- StatCare Pulmonary Consultants and Center for Biomedical Research, Knoxville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Clinical Trials Center of Middle Tennessee, LLC, Franklin
- StatCare Pulmonary Consultants, PLLC, Knoxville
- The Vanderbilt Lung Institute, Nashville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.